1. India Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Titan Biotech Limited

Titan Biotech Limited

TITANBIO.BO
Titan Biotech LimitedIN flagBombay Stock Exchange
408.55
INR
+19.45
- -
16.88BMarket Cap

Total Valuation

Titan Biotech Limited carries a market capitalization of 16.88B, placing it among publicly traded companies globally. Its enterprise value stands at 18.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap16.88B
Enterprise Value18.95B

Share Statistics

Titan Biotech Limited currently has 41.32M shares outstanding.

Shares Outstanding41.32M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Titan Biotech Limited trades at a trailing price-to-earnings ratio of 63.27. The price-to-sales ratio is 9.17, and the price-to-book ratio stands at 228.81.

PE Ratio63.27
PS Ratio9.17
PB Ratio228.81
P/TBV Ratio10.42
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Titan Biotech Limited trades at an EV/EBITDA multiple of 56.26 and an EV/FCF ratio of 2,883.45. The EV/Sales ratio of 9.19 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 56.26 provides insight into valuation relative to core operating earnings.

EV / Sales9.19
EV / EBITDA56.26
EV / EBIT56.26
EV / FCF2,883.45

Financial Position

Titan Biotech Limited maintains a current ratio of 3.28, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.14, indicating elevated leverage, while an interest coverage ratio of 36.85 demonstrates strong ability to service its debt obligations.

Current Ratio3.28
Quick Ratio0.07
Debt / Equity3.14
Debt / EBITDA0.17
Interest Coverage36.85

Financial Efficiency

Titan Biotech Limited posts a return on equity of 361.64 and a return on invested capital of 14.05.

Return on Equity (ROE)361.64
Return on Assets (ROA)15.38
Return on Invested Capital (ROIC)14.05
Return on Capital Employed (ROCE)244.03
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.80

Taxes

Over the trailing twelve months, Titan Biotech Limited has paid 107.27M in income taxes, reflecting an effective tax rate of 28.10.

Income Tax107.27M
Effective Tax Rate28.10

Stock Price Statistics

Titan Biotech Limited's stock has gained approximately 350.39136% over the past 52 weeks. The 50-day moving average sits at 441.54, while the 200-day moving average is 305.85.

Beta (5Y)N/A
52-Week Price Change350.39136%
50-Day Moving Average441.54
200-Day Moving Average305.85
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Titan Biotech Limited generated 2.06B in revenue and converted that into 298.85M in net income, yielding earnings per share of 7.07. EBITDA reached 336.78M, while operating income came in at 336.78M.

Revenue2.06B
Gross Profit1.10B
Operating Income336.78M
Pretax Income381.75M
Net Income298.85M
EBITDA336.78M
EBIT336.78M
Earnings Per Share (EPS)7.07

Balance Sheet

Titan Biotech Limited holds 18.73M in cash and equivalents against 57.07M in total debt, resulting in a net debt position of 21.93M. Total book value stands at 82.64M, with working capital of 592.80M providing operational flexibility.

Cash & Cash Equivalents18.73M
Total Debt57.07M
Net Debt21.93M
Equity (Book Value)82.64M
Book Value Per Share2.00
Working Capital592.80M

Margins

Titan Biotech Limited operates with a gross margin of 53.35, reflecting its pricing power and cost economics. The operating margin of 16.33 and net profit margin of 14.49 provide insight into operational efficiency.

Gross Margin53.35
Operating Margin16.33
Pretax Margin18.51
Profit Margin14.49
EBITDA Margin16.33

Stock Splits

Titan Biotech Limited's most recent stock split took place on February 20, 2026 with a 1:5 split ratio.

Last Split Date2/20/2026
Split Ratio1:5

Scores

Titan Biotech Limited posts an Altman Z-Score of 36.90, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score36.90